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Methods: The mouse femoral artery wire injury model was performed
in 10-week-old male C57BL/6 mice. Treatment groups included control,
injury, and injuryNO (n 5/group). Arteries were harvested at 24 hours,
3 days, 7 days, and 2 weeks after injury and assessed for Sca1 cells using
immunofluorescence. Sca1 staining was graded on a scale of 0 to 4 for the
intima, media, and adventitia in four high-power fields per section.
Results: Sca1 staining in the adventitia after injury significantly
decreased at 24 hours (1.9  0.13, P  .001) and 3 days (1.9  0.12, P 
.001) and returned to baseline by 2 weeks. Sca1 staining in the media after
injury significantly increased by 7 days (2.3 0.23), and persisted to 2 weeks
(2.4 0.19) after injury (P .001). Sca1 staining in the intima after injury
also significantly increased by 7 days (3.0  0.14) and persisted to 2 weeks
(2.7 0.14) after injury (P .001). In the adventitia, NOhad no significant
effect on Sca1 levels. However in the media, NO significantly decreased
Sca1 levels at 7 days (1.5 0.19) vs injury alone (P .002). In the intima,
NO significantly decreased Sca1 levels at 7 days (2.2  0.23) and 2 weeks
(2.3  0.18) vs. injury alone (P  .001 and P  .03, respectively).
Conclusions: The level of resident Sca1 stem cells decreases in the
adventitia after arterial injury and then increases in the media and neointima,
suggesting that Sca1 stem cells contribute to the formation of neointimal
hyperplasia. NO decreases Sca1 levels in the intima and media after injury,
suggesting one mechanism by which NO may inhibit the formation of
neointimal hyperplasia. Together, these data suggest an important role of
Sca1 stem cells in the arterial injury process. Identification of the mecha-
nism of Sca1 inhibition by NO could lead to a therapy to prevent neoin-
timal hyperplasia.
Patients With Chronic Obstructive Pulmonary Disease Have Shorter
Survival but Superior Endovascular Outcomes After Endovascular
Aneurysm Repair
Moqueet A. Qureshi, MD, Roy K. Greenberg, MD, Tara M. Mastracci,
MD, Matthew J. Eagleton, MD, and Adrian V. Hernandez, PhD. Vascular
Surgery/Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
Objectives: This study was conducted to determine the effect of
pulmonary disease on outcomes after endovascular abdominal (EVAR) and
thoracoabdominal (eTAAA) aneurysm repair.
Methods: A prospective study of high-risk patients undergoing EVAR
and eTAAA repair between 1998 and 2009 was used to contrast clinical and
endovascular outcomes between chronic obstructive pulmonary disease
(COPD; group 1) and non-COPD patients (group 2). COPD patients were
classified in accordance with the severity of their pulmonary disease using the
criteria. Survival, morphologic changes, and complications were assessed
using Cox models and life-table analyses. The cause and timing of deaths
between the groups was compared.
Results:A total of 905 patients were analyzed, of which 289 (32%) had
COPD. EVAR was performed in 334 patients (37%), whereas fenestrated/
branched devices were used in the remaining 571 (63%). Group 1 patients
were younger (73.5  6.7 vs 75.6  8.2 years), had a better glomerular
filtration rate (67.8  25.8 vs 61.0  23.3 mL/min/1.73 m2), had higher
hematocrits (41.6 5.0 vs 40.5 4.6), and had more extensive aneurysms.
Mean follow-up was 39.5  30.9 months. Early (3% vs 3%) and late (2% vs
1%) aneurysm-related deaths were similar between the two groups. Survival
in group 1 was lower than that in group 2 (P .0001; Fig 1). Furthermore,
survival in group 1 was dependent upon the severity of disease, with Global
Initiative for Chronic Obstructive LungDisease classification I and II similar
to group 2, and classifications III and IV demonstrating lower survival rates
(P  .0001; Fig 2). Relevant pulmonary function test variables included a
lower forced expiratory volume in 1 second and forced expiratory flow
25%-75%, which were associated with decreased survival. Surrogate endo-
vascular outcome analyses demonstrated that group 1 patients had fewer
endoleaks (20% vs 25%, P  .05) and more rapid sac shrinkage rate (1.66
mm/y difference, P  .001).
Conclusions: The perioperative risk of mortality between COPD and
non-COPD patients is eliminated when endovascular techniques are used.
Long-term survival in COPD patients is most strongly related to the severity
of their disease, and forced expiratory volume in 1 second and forced
expiratory flow 25%-75%, are reasonable indicators of poor long term
outcomes. Morphologic changes following EVAR and eTAAA repair are
more favorable in COPD patients, with a lower endoleak rate and faster sac
shrinkage.
Are Lower Extremity Endovascular Procedures Associated with Fewer
Hospital Readmissions?
ToddR.Vogel,MD,Robin L. Kruse, PhD, andW.KirtNichols,MD. University
ofMissouri Hospitals and Clinics, Columbia, Mo
Objectives: As pressure to contain health care costs increases, there has
been greater scrutiny of readmissions in the vascular surgery population. The
objective of this study was to evaluate postoperative readmissions after open
(OPEN) and endovascular (ENDO) lower extremity (LE) procedures for
PAD (peripheral artery disease).
Methods: Inpatients with PAD and LE procedures were selected from
the Cerner Health Facts database between October 2008 and December
2010, using International Classification of Diseases-9 Edition-ClinicalMod-
ification diagnosis codes (claudication, rest pain, and ulceration/gangrene)
and procedure codes for LE revascularization (ENDO and OPEN). Read-
mission30 days of discharge was determined. Charlson comorbidity index
was used to adjust for comorbidities, and 2 and multivariable logistic
regression were used to compare patients who received ENDO and OPEN
procedures.
Results:Of 453,257 index admissions, 10,103 patients were identified
with a diagnosis of PAD. Combining PAD with elective LE procedures
during the index admission, 657 and 678 underwent OPEN and ENDO,
respectively. Overall readmission rates or OPEN and ENDO for claudica-
tion, rest pain, and ulceration/gangrene were 9.68% vs 12.50% (P  .29),
14.29% vs 18.60% (P  .38), and 17.9% vs 20% (P  .60); respectively.
Readmission increased by the severity of the diagnosis for both OPEN and
ENDO (P  .0001). Men comprised 59% of the cohort, and readmission
rates were not statistically different by sex (P .25). Race was not associated
with procedure performed (P  .7). After adjustment for age, race, sex,
comorbidities, and procedure, patients with ulceration/gangrene (odds
ratio [OR], 1.7; 95% confidence interval [CI], 1.17-2.41), non-Caucasian
race (OR, 1.5; 95% CI, 1.08-2.19), and increased numbers of comorbidities
(OR, 1.1; 95% CI, 1.01-1.22) were more likely to be readmitted. Diagnoses
at readmission were similar between groups.
Conclusions: Less invasive endovascular procedures were not associ-
ated with decreased readmission rates compared with open surgery. Read-
mission rates for claudicants were unexpectedly high, with an overall rate of
11%. Predictors of readmission included black race and increased severity of
disease. Further examination exploring reasons for readmission are required
to decrease readmission rates in the vascular surgery population.
Midterm Results of Replacement of Synthetic Graft and Arterial Infec-
tion in the Groin With Femoropopliteal Vein
Amanda J. Kravetz, MD. Department of Vascular and Endovascular Sur-
gery, Mayo Clinic, Rochester, Minn. Sponsored by: Manju Kalra, MD,
Rochester, Minn.
Objectives: Infection of synthetic grafts or femoral arteries in the groin
is a challenging problem to treat. Femoropopliteal vein (FPV) is an ideal
conduit, but extensive replacement of infected aortic grafts with FPV has
been associated with significant morbidity. The aim of this study was to
evaluate early and long-term outcome of limited replacement with FPV of
infected femoral arteries/grafts in the groin.
Methods: Data from 37 patients who underwent excision of infected
femoral grafts and replacement with FPV over an 18-year period from 1994
to 2012 were retrospectively analyzed.
Results: Surgical intervention was performed in 41 limbs of 27 men
and 10 women (mean age, 67.5 years) at a median of 2.5 years after the
original synthetic implantation (aortofemoral n 21, femorofemoral n 3,
femorodistal n 5, patch angioplasty n 2) or, on average, 22.2 days after
cardiac catheterization (n  6) and one mycotic aneurysm. Presentation
included draining sinus (n  7), abscess (n  4), persistent fevers (n  6),
and pseudoaneurysm (n  10; intact, 4; ruptured, 6). Twenty-five patients
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(61%) underwent muscle flap cover of the FPV reconstruction. In-hospital/
30-day mortality was 5.4% (2 of 37); one from respiratory failure 20 days
postoperatively, and the second, a 93-year-old woman, after withdrawal of
care at 24 hours. No patients required fasciotomy, and five wound hemato-
mas required reoperation. Focal femoropopliteal vein thrombosis occurred
in five limbs. Over a mean follow-up of 2.5 years (range, 0.03-13.3) 11
patients died of unrelated causes at a mean of 3.7 years (range, 0.2-10.6
years). Graft reintervention was required in seven patients during follow-up
for graft thromboses (n  2) stenoses (n  2), and anastomotic false
aneurysms (n  3). Apart from the latter, there was no other suggestion of
graft reinfection in any patient. Major limb loss occurred in one patient at 6
months despite a patent graft. Long-term FPV harvest morbidity included
mild leg swelling in 10 patients.
Conclusions: Replacement of infected synthetic grafts/femoral arter-
ies in the groin with FPV is safe and results in excellent limb preservation and
freedom from reinfection. FPV should be considered the preferred conduit
in good-risk patients with infection limited to the groin.
Secondary Interventions After Elective Thoracic Endovascular Aortic
Repair (TEVAR) for Degenerative Aneurysms: Incidence and
Outcomes
Cheong J. Lee, MD, Heron E. Rodriguez, MD, S. Chris Malaisrie, MD,
Melina R. Kibbe, MD, and Mark K. Eskandari, MD. Division of Vascular
Surgery and Cardiothoracic Surgery, Northwestern University, Chicago, Ill
Objectives: We assessed the incidence and outcomes of secondary
interventions (SI) after elective thoracic endovascular aortic repair (TEVAR)
for aneurysmal disease.
Methods:An institutional review of TEVAR performed for descending
thoracic aneurysms (DTAA) between 2000 and 2011 was performed from a
prospectively maintained database. Only elective cases of TEVAR for DTAA
using commercially available endografts were selected. The incidence of
unplanned graft-related SI (ie, open conversion or proximal or distal exten-
sions) was examined. Outcomes of each SI were then analyzed.
Results:We identified 83 patients who underwent elective TEVAR for
DTAA. Eight patients (9.52%) subsequently required graft-related SIs. The
mean interval to SI was 31.8 months. Patients who required SI were
significantly younger than patients who did not require SI (mean age,
57.5 11.6 vs 69.3 11.4 years, P .05). Endoleak was themost common
indication for SI: five patients (62.5%) underwent SI for a type I endoleak (4
type IA, 1 type IB), one for aneurysmal progression without endoleak, one
for type II endoleak, and 1 for type III endoleak. In the SI group, two
patients (25%) required open conversion, five (62.5%) required secondary
TEVAR (3 proximal and 1 distal extensions, and 1 relining), and 1 required
endovascular coiling only. In the SI group, clinically relevant perioperative
events occurred in three patients with one stroke (12.5%) and two access
complications (25%). Operative mortality (30 day) was zero with one
aneurysm-related late death occurring at 2 years after SI. Factors that
predispose the need for SI were fusiform morphology of the aneurysm (P
.05) and extent of graft coverage in the proximal landing zone (P  .05).
Size of the aneurysm treated and the type of device used were not significant
factors leading to SI.
Conclusions: Short-term and midterm results of elective TEVAR for
DTAA demonstrate good durability with acceptable rates of graft-related SI.
All currently available commercial endografts seem to perform equally in this
setting. Age, fusiform aneurysm morphology, and extent of proximal land-
ing zones were significant factors that led to subsequent SI. When SI is
necessary, most issues can be resolved via endovascular means. Conversion
to open repair, however, is not insignificant and may lead to increased
operative morbidity.
Rate of Malignancy Detected on Postendovascular Aneurysm Repair
Surveillance Computed Tomography Angiogram
Dawn M. Coleman, MD, Jonathan L. Eliason, MD, Jordan P. Knepper,
MD, Enrique Criado, MD, Gilbert R. Upchurch, MD, and John E. Rect-
enwald, MD. Department of Surgery, Section of Vascular Surgery, Univer-
sity of Michigan, Ann Arbor, Mich; and University of Virginia, Charlottes-
ville, Va
Objectives: Intuitively, patients with aortic aneurysms represent a
high-risk population for the development of a variety of tumors. We sought
to identify the incidence and pattern of new cancer diagnoses in a cohort
after endovascular aneurysm repair (EVAR), and to determine the rate with
which these diagnoses were obtained by surveillance computed tomography
angiogram (CTA).
Methods: A prospective cohort of 331 patients undergoing endovas-
cular exclusion of 286 abdominal aortic aneurysms, 31 thoracoabdominal
and descending thoracic aortic aneurysms, and 14 isolated common iliac
artery aneurysms between 1997 and 2009 was analyzed. We identified all
patients diagnosed with new thoracic and abdominal tumors in addition to
leukemia and lymphoma.
Results: Of this cohort, 193 patients (58%) carried a preoperative
history of malignancy. The most common tumors encountered included
prostate (n  28), lung (n  14), and breast (n  10). During a median
follow-up of 37 months, 29 patients (8.7%) developed 31 tumors. Thirteen
of these tumors (45%) included newly diagnosed lung cancers in addition to
renal cell carcinoma (n  3), colon cancer (n  2), prostate cancer (n  2),
and lymphoma (n  2). Sixteen of these tumors (55%) were identified on
post-EVAR surveillance CTA. The most common tumor encountered on
post-EVAR surveillance CT was lung cancer (n  7), 80% of which were
stage I or “limited” at the time of diagnosis; all renal cell carcinomas (n 3)
were identified in this fashion. Mean interval to diagnosis after EVAR was
31.3 months.
Conclusions: Compared with the general population, patients with
aortic aneurysms carry a heightened risk of cancer development. Serial CT
scans for post-EVAR surveillance may reveal a high rate of malignancy in this
population, such that vascular surgeons should remain observant and pre-
pared to arrange for the appropriate oncologic follow-up. It seems possible
that post-EVAR surveillance may allow for earlier cancer detection, and an
effort to further identify whether this early detection offers a clinical or
survival benefit is warranted.
Aortic Surgery for Aortic Graft Infections: Defining National Bench-
marks for Standards of Care
Leonid Grossman, Prateek K. Gupta, MD, Bala Ramanan, MD, Jason N.
MacTaggart, MD, B. Timothy Baxter, MD, Xiang Fang, PhD, Thomas G.
Lynch, MD, and Iraklis I. Pipinos, MD. Creighton University and Depart-
ment of Surgery, Creighton University; and University of Nebraska Medical
Center and VA Nebraska and Western Iowa Health Care System, Omaha,
Neb
Objectives: Published literature on postoperative outcomes after aortic
surgery for prosthetic aortic graft infection (AGI) is limited by relatively
small sample sizes resulting in lack of national benchmarks for quality of care.
We report in-hospital outcomes after aortic surgery for AGI and identify
factors associated with postoperative complications using the Nationwide
Inpatient Sample (NIS) database.
Methods: Patients who underwent aortic graft resection for AGI were
identified from the 2002 to 2008 NIS database, a multicenter database
capturing 20% of all United States admissions. Multivariable logistic regres-
sion analyses were performed.
Results: In 394 patients (73.4% men) who underwent aortic surgery
for AGI, median age was 72 years. Fifty-three percent of the admissions were
emergent or urgent. Median hospital volume of aortic surgery for AGI
during the study period was one case. A significant trend for decreasing
number of AGIs per year was observed during the study span (Pearson’s
correlation r	0.96; P .0006). During the same time span, a significant
correlation was also seen with decrease in open, and increase in endovascular
aortic aneurysm repairs in the NIS database (Fig). In-hospital rates of overall
postoperative morbidity and mortality were 68.3% and 19.8%, respectively.
In-hospital rates of postoperative respiratory failure, renal failure, and cardiac
arrest were 35.5%, 14.2%, and 8.9%, respectively. Median length of stay was
26 days, with median hospital charges being $184,162. On multivariable
analysis, increase in age per year (odds ratio, 1.07; 95% confidence interval,
1.03-1.12) was independently associated with postoperative morbidity,
whereas higher hospital volume for this procedure was protective (odds
ratio, 0.71; 95% confidence interval, 0.56-0.89). On multivariable analysis,
Fig.
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